ARDX
Ardelyx Inc
Price:  
6.35 
USD
Volume:  
4,065,117.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-161.2%
Upside

As of 2024-06-16, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -27.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,549.46 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -57.15 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.2x - 15.8x 12.2x
Forward P/E multiples 13.8x - 20.6x 17.4x
Fair Price (3.64) - (4.13) (3.89)
Upside -157.4% - -165.1% -161.2%
6.35 USD
Stock Price
(3.89) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-14 -27.11
2024-06-13 -27.68
2024-06-12 -28.50
2024-06-11 -28.26
2024-06-10 -27.56
2024-06-07 -27.52
2024-06-06 -28.71
2024-06-05 -30.30
2024-06-04 -29.24
2024-06-03 -29.44
2024-05-31 -29.20
2024-05-30 -28.87
2024-05-29 -28.18
2024-05-28 -29.36
2024-05-24 -28.75
2024-05-23 -31.57
2024-05-22 -33.13
2024-05-21 -32.72
2024-05-20 -33.58
2024-05-17 -33.09
2024-05-16 -33.01
2024-05-15 -33.25
2024-05-14 -33.01
2024-05-13 -33.95
2024-05-10 -32.92
2024-05-09 -34.11
2024-05-08 -35.83
2024-05-07 -39.23
2024-05-06 -38.57
2024-05-03 -36.81
2024-05-02 -28.91
2024-05-01 -28.18
2024-04-30 -27.32
2024-04-29 -27.56
2024-04-26 -27.40
2024-04-25 -26.95
2024-04-24 -27.44
2024-04-23 -27.27
2024-04-22 -27.77
2024-04-19 -27.64
2024-04-18 -27.48
2024-04-17 -27.93
2024-04-16 -28.58
2024-04-15 -28.95
2024-04-12 -30.02
2024-04-11 -31.29
2024-04-10 -30.30
2024-04-09 -30.47
2024-04-08 -31.08
2024-04-05 -31.82